American Healthcare REIT (NYSE:AHR) Price Target Raised to $30.00 at Royal Bank of Canada

American Healthcare REIT (NYSE:AHR) had its price target increased by Royal Bank of Canada from $28.00 to $30.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective would suggest a potential upside of 9.29% from the stock’s previous close.

AHR has been the topic of several other reports. JMP Securities boosted their price target on shares of American Healthcare REIT from $18.00 to $30.00 and gave the company a “market outperform” rating in a report on Friday, September 20th. Morgan Stanley boosted their price target on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. KeyCorp upped their price objective on shares of American Healthcare REIT from $16.00 to $27.00 and gave the stock an “overweight” rating in a report on Monday, September 16th. Bank of America upped their price objective on shares of American Healthcare REIT from $27.00 to $31.00 and gave the stock a “buy” rating in a report on Tuesday, September 24th. Finally, Truist Financial upped their price objective on shares of American Healthcare REIT from $27.00 to $29.00 and gave the stock a “buy” rating in a report on Friday. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, American Healthcare REIT presently has an average rating of “Moderate Buy” and an average price target of $25.13.

American Healthcare REIT Trading Up 1.0 %

NYSE AHR traded up $0.27 on Monday, hitting $27.45. 339,933 shares of the stock were exchanged, compared to its average volume of 1,454,929. The company’s 50-day moving average price is $25.35 and its two-hundred day moving average price is $19.43. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.29. American Healthcare REIT has a 52-week low of $12.63 and a 52-week high of $27.77. The company has a market capitalization of $3.61 billion and a price-to-earnings ratio of -57.19.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.32 by ($0.35). American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.87%. The company had revenue of $523.81 million for the quarter, compared to analysts’ expectations of $474.26 million. The business’s quarterly revenue was up 12.8% on a year-over-year basis. Research analysts predict that American Healthcare REIT will post 1.41 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of AHR. Kozak & Associates Inc. acquired a new position in American Healthcare REIT during the 3rd quarter worth $28,000. Kiely Wealth Advisory Group Inc. acquired a new position in shares of American Healthcare REIT during the second quarter valued at about $30,000. Amalgamated Bank acquired a new position in shares of American Healthcare REIT during the second quarter valued at about $33,000. Quarry LP acquired a new position in shares of American Healthcare REIT during the third quarter valued at about $33,000. Finally, Tidemark LLC acquired a new position in shares of American Healthcare REIT during the third quarter valued at about $44,000. Institutional investors and hedge funds own 16.68% of the company’s stock.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.